Cardiovascular risk in general practice in France: cardiovascular risk week

Study identifier:NIS-CFR-XXX-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Cardiovascular risk in general practice in France

Medical condition

Healthy

Phase

Healthy volunteers

Yes

Study drug

Sex

All

Actual Enrollment

9246

Study type

Observational

Age

50 Years +

Date

Study Start Date: 01 Oct 2011

Primary Completion Date: 01 Oct 2011

Study Completion Date: 01 Oct 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
1 For this group of patients, the cardiovascular risk will be evaluated by several tools: the SCORE scale, the Framingham 2008 scale d'Agostino and the 1998 scale Wilson ;	-

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=788&filename=CSR-NIS-CFR-XXX-2011-1.pdf
Download
CSR-NIS-CFR-XXX-2011-1.pdf
Download
Trial Results Summaries
Available here

Cardiovascular risk in general practice in France: cardiovascular risk week

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Exclusion Criteria

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=788&filename=CSR-NIS-CFR-XXX-2011-1.pdf

CSR-NIS-CFR-XXX-2011-1.pdf

Trial Results Summaries

Contacts

Investigators

Principal Investigator